Certificate number:RU.77.99.88.003.E.000828.02.16 Date of registration and renewal:19.02.2016 Dosage form: & nbspTablets weighing 309.0 mg ± 5%. Classification "Composition" & nbsp Other dietary supplements Classification "Clinical" & nbsp Supplements supporting the functions of the musculoskeletal system Composition: & nbspComposition: Boswellia serrate resin extract, chicken cartilage extract, cholecalciferol, E170i, E464, E570, E468, E171, E1200, E460i, E552, E551, E553i, medium chain triglycerides. Scope: & nbspFor realization to the population as a biologically active food additive - an additional source of vitamin D containing boswellic acids. Suggested Usage: & nbspAdults take 1 tablet a day with meals. Contraindications:Individual intolerance of components, pregnancy, breast-feeding. Special instructions:Before use, it is recommended to consult a doctor. Shelf life:36 months. Storage conditions:Store in a dry place inaccessible to children, at temperatures from + 15 ° C to + 25 ° C. Research protocols:Expert conclusion of FGBICU "NII Nutrition" №72 / E-62 / б-16 of 04/02/2016. ManufacturersREXALL Sundown, Inc. USA Recipient:NAVITA, LLCNAVITA, LLC Information update date: & nbsp2016-03-26 Instructions